amonafide has been researched along with B16 Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberts, DS; Dorr, RT; Remers, WA; Sami, SM | 1 |
1 other study(ies) available for amonafide and B16 Melanoma
| Article | Year |
|---|---|
2-substituted 1,2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones. A new class of antitumor agent.
Topics: Animals; Antineoplastic Agents; Female; Humans; Isoquinolines; Leukemia L1210; Leukemia P388; Male; Melanoma, Experimental; Mice; Mice, Inbred DBA; Ovarian Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 1993 |